Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2010-2024 | MKKGY

Merck annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending June 30, 2024 was $3.482B, a 0.95% increase year-over-year.
  • Merck gross profit for the twelve months ending June 30, 2024 was $13.149B, a 7.19% decline year-over-year.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
  • Merck annual gross profit for 2021 was $14.595B, a 19.42% increase from 2020.
  
Merck Annual Gross Profit
(Millions of US $)
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
2009 $10,807
Merck Quarterly Gross Profit
(Millions of US $)
2024-06-30 $3,482
2024-03-31 $3,267
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $2,345
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.192B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.770B 30.70
Takeda Pharmaceutical (TAK) Japan $44.101B 9.18
Astellas Pharma (ALPMY) Japan $19.074B 17.57
Sandoz Group AG (SDZNY) Switzerland $18.921B 0.00
United Therapeutics (UTHR) United States $16.524B 16.25
Summit Therapeutics (SMMT) United States $13.635B 0.00
Neurocrine Biosciences (NBIX) United States $12.746B 33.75
Shionogi (SGIOY) Japan $11.978B 12.00
Catalent (CTLT) United States $11.150B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.948B 0.00
Orion OYJ (ORINY) Finland $6.605B 18.57
Corcept Therapeutics (CORT) United States $6.204B 46.99
Ionis Pharmaceuticals (IONS) United States $5.700B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.322B 0.00
PTC Therapeutics (PTCT) United States $4.016B 0.00
Dyne Therapeutics (DYN) United States $2.980B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.655B 15.87
Centessa Pharmaceuticals (CNTA) United Kingdom $2.235B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.173B 0.00
Soleno Therapeutics (SLNO) United States $2.156B 0.00
Xencor (XNCR) United States $1.878B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.814B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Indivior (INDV) United States $1.548B 6.31
Guardian Pharmacy Services (GRDN) United States $1.537B 0.00
Ocular Therapeutix (OCUL) United States $1.536B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.529B 0.00
Harrow (HROW) United States $1.491B 0.00
Ardelyx (ARDX) United States $1.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.303B 0.00
ARS Pharmaceuticals (SPRY) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.117B 0.00
Collegium Pharmaceutical (COLL) United States $1.010B 5.52
Bioventus (BVS) United States $0.997B 31.49
Cronos Group (CRON) Canada $0.791B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
USANA Health Sciences (USNA) United States $0.763B 14.14
Oruka Therapeutics (ORKA) United States $0.734B 0.00
Tourmaline Bio (TRML) United States $0.658B 0.00
Elite Pharmaceuticals (ELTP) United States $0.646B 0.00
Altimmune (ALT) United States $0.629B 0.00
ProKidney (PROK) United States $0.621B 0.00
Esperion Therapeutics (ESPR) United States $0.611B 0.00
Verve Therapeutics (VERV) United States $0.606B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.579B 0.00
Savara (SVRA) United States $0.567B 0.00
OmniAb (OABI) United States $0.562B 0.00
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Siga Technologies (SIGA) United States $0.511B 5.96
Xeris Biopharma Holdings (XERS) United States $0.504B 0.00
Korro Bio (KRRO) United States $0.501B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.476B 193.21
Akebia Therapeutics (AKBA) United States $0.465B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
KalVista Pharmaceuticals (KALV) United States $0.444B 0.00
Aquestive Therapeutics (AQST) United States $0.439B 0.00
Larimar Therapeutics (LRMR) United States $0.396B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.380B 0.00
Sage Therapeutics (SAGE) United States $0.354B 0.00
4D Molecular Therapeutics (FDMT) United States $0.351B 0.00
Avita Medical (RCEL) United States $0.341B 0.00
Nature's Sunshine Products (NATR) United States $0.310B 18.42
Lyell Immunopharma (LYEL) United States $0.292B 0.00
Aldeyra Therapeutics (ALDX) United States $0.287B 0.00
Aclaris Therapeutics (ACRS) United States $0.283B 0.00
Lexeo Therapeutics (LXEO) United States $0.278B 0.00
Silence Therapeutics (SLN) United Kingdom $0.245B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Nektar Therapeutics (NKTR) United States $0.218B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.217B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Heron Therapeutics (HRTX) United States $0.186B 0.00
Inhibikase Therapeutics (IKT) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.182B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Cassava Sciences (SAVA) United States $0.166B 0.00
Achieve Life Sciences (ACHV) Canada $0.151B 0.00
Nanobiotix S.A (NBTX) France $0.148B 0.00
Century Therapeutics (IPSC) United States $0.143B 0.00
CytoDyn (CYDY) United States $0.143B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Cardiol Therapeutics (CRDL) Canada $0.128B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Fractyl Health (GUTS) United States $0.125B 0.00
Journey Medical (DERM) United States $0.122B 0.00
Pyxis Oncology (PYXS) United States $0.119B 0.00
Context Therapeutics (CNTX) United States $0.117B 0.00
Regulus Therapeutics (RGLS) United States $0.107B 0.00
Karyopharm Therapeutics (KPTI) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.101B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Assertio Holdings (ASRT) United States $0.098B 25.62
Arch Biopartners (ACHFF) Canada $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
Vivani Medical (VANI) United States $0.086B 0.00
OptiNose (OPTN) United States $0.081B 0.00
Metagenomi (MGX) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.071B 0.00
Scienture Holdings (SCNX) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.066B 0.00
AlloVir (ALVR) United States $0.061B 0.00
CASI Pharmaceuticals (CASI) China $0.061B 0.00
Champions Oncology (CSBR) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
BioVie (BIVI) United States $0.055B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
Nutriband (NTRB) United States $0.051B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Carisma Therapeutics (CARM) United States $0.035B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.030B 0.00
Natural Alternatives (NAII) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
CERo Therapeutics Holdings (CERO) United States $0.027B 0.00
BioLineRx (BLRX) Israel $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
GlycoMimetics (GLYC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Cosmos Health (COSM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
NRx Pharmaceuticals (NRXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Talphera (TLPH) United States $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Oncternal Therapeutics (ONCT) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.12
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 39.31